Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
1:00PMiHub NewswireFeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent
07/03/202412:11PMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:RYBPFRoyal Bank (PK)
07/03/202412:10PMBusiness WireCintas Corporation Announces Webcast for Fourth Quarter Fiscal Year 2024 ResultsNASDAQ:CTASCintas Corporation
07/03/202412:09PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:FBGXUBS AG FI Enhanced Large Cap Growth
07/03/202412:09PMBusiness WireThe Roxborough Group and Bendetti Close on $38.6 Million Recapitalization of 195,603 Square Foot Multi-Tenant Industrial Park in Las Vegas
07/03/202412:07PMBusiness WireXsolla Partners With Curve Games to Promote Indie Games Globally and Drive the Launch of Upcoming Action RPG/Social Sim Title
07/03/202412:07PMPR Newswire (Canada)WICC raises another $200,000 towards its goal of $25 million by 2025
07/03/202412:05PMGlobeNewswire Inc.Clark Construction Announces Inaugural Graduates from Central Virginia Training Program for Small, Diverse-Owned Firms
07/03/202412:05PMGlobeNewswire Inc.URW SE - Information on total number of voting rights and shares in the share capital as at June 30, 2024XE:1BR1Unibail Rodamco Westfield SE
07/03/202412:05PMGlobeNewswire Inc.URW SE - Information on total number of voting rights and shares in the share capital as at June 30, 2024BIT:URWUnibail Rodamco Westfield SE
07/03/202412:05PMGlobeNewswire Inc.URW SE - Informations relatives au nombre total de droits de vote et d'actions composant le capital social au 30 juin 2024XE:1BR1Unibail Rodamco Westfield SE
07/03/202412:05PMGlobeNewswire Inc.URW SE - Informations relatives au nombre total de droits de vote et d'actions composant le capital social au 30 juin 2024BIT:URWUnibail Rodamco Westfield SE
07/03/202412:05PMGlobeNewswire Inc.URW SE - Informations relatives au nombre total de droits de vote et d'actions composant le capital social au 30 juin 2024TG:1BR1Unibail Rodamco Westfield SE
07/03/202412:05PMBusiness WireResources Connection, Inc. to Announce Fourth Quarter and Full Fiscal Year 2024 Results on July 18, 2024NASDAQ:RGPResources Connection Inc
07/03/202412:05PMGlobeNewswire Inc.URW SE - Information on total number of voting rights and shares in the share capital as at June 30, 2024TG:1BR1Unibail Rodamco Westfield SE
07/03/202412:03PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJJP Morgan Alerian MLP
07/03/202412:03PMBusiness WireHARMAN und CARIAD kündigen wachsendes Ökosystem mit neuen Apps in Fahrzeugen des Volkswagen-Konzerns an, die in den nächsten Wochen auf den Markt kommen
07/03/202412:02PMGlobeNewswire Inc.Transaction in Own SharesLSE:SHELShell Plc
07/03/202412:02PMGlobeNewswire Inc.Transaction in Own SharesEU:SHELLShell Plc
07/03/202412:02PMGlobeNewswire Inc.Transaction in Own SharesEU:SHELLShell Plc
07/03/202412:02PMGlobeNewswire Inc.Transaction in Own SharesTG:R6C0Shell Plc
07/03/202412:02PMGlobeNewswire Inc.Transaction in Own SharesLSE:SHELShell Plc
07/03/202412:02PMGlobeNewswire Inc.Transaction in Own SharesNYSE:SHELShell plc
07/03/202412:02PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
07/03/202412:01PMPR Newswire (US)National Western and Prosperity Life Group Announce Expected Closing Date for $1.9 Billion Cash MergerNASDAQ:NWLINational Western Life Group Inc
07/03/202412:00PMGlobeNewswire Inc.Fly Play hf.: Rūta Dabašinskaitė-Vitkė Appointed New CFO of PLAY airlines  
07/03/202412:00PMBusiness WireABIONYX Pharma : Information relative au nombre total de droits de vote et d’actions composant le capital socialEU:ABNXAbionyx Pharma
07/03/202412:00PMGlobeNewswire Inc.Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371TG:6OPOSE Immunotherapeutics
07/03/202412:00PMGlobeNewswire Inc.OSE Immunotherapeutics et Boehringer Ingelheim poursuivent l’avancée du développement clinique du traitement first-in-class SIRPα BI 770371 en immunologie du cancerEU:OSEOSE Immunotherapeutics
07/03/202412:00PMGlobeNewswire Inc.Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371LSE:0RADOse Immunotherapeutics Sa

Your Recent History

Delayed Upgrade Clock